title: Hyporeninemic hypoaldosteronism from secondary amyloidosis.
authors.affiliation: Kidney Center, Toranomon Hospital, Tokyo, Japan. ftakemoto-ind@umin.ac.jp
authors.forename: Fumi
authors.initials: F
authors.lastname: Takemoto
authors.forename: Yoshifumi
authors.initials: Y
authors.lastname: Ubara
authors.forename: Shinya
authors.initials: S
authors.lastname: Kaname
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Katori
authors.forename: Naoki
authors.initials: N
authors.lastname: Sawa
authors.forename: Junichi
authors.initials: J
authors.lastname: Hoshino
authors.forename: Tatsuya
authors.initials: T
authors.lastname: Suwabe
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Higa
authors.forename: Shohei
authors.initials: S
authors.lastname: Nakanishi
authors.forename: Michio
authors.initials: M
authors.lastname: Nagata
authors.forename: Kenichi
authors.initials: K
authors.lastname: Ohashi
authors.forename: Kenmei
authors.initials: K
authors.lastname: Takaichi
mesh_terms: D000368:Aged; D000686:Amyloidosis / Q000150:complications* / Q000628:therapy; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001706:Biopsy; D005260:Female; D005438:Fludrocortisone / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006994:Hypoaldosteronism / Q000150:complications* / Q000628:therapy; D007668:Kidney / Q000473:pathology / Q000601:surgery; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D005438:Fludrocortisone